Aurinia Pharmaceuticals Inc - Common Shares (NQ:AUPH)

15.72 -0.11 (-0.69%)

Delayed Quote Updated: 4:00 PM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Aurinia Pharmaceuticals Inc - Common Shares

< Previous 1 2

...

6 7 8 9 10 11 12 13 Next >

Why Aurinia Pharmaceuticals Stock Crashed in After-Hours Trading on Friday ↗

November 20, 2021

A $250 mixed shelf offering isn't sitting well with the biotech's shareholders.

Via The Motley Fool

Aurinia Pharmaceuticals to Present at the 2021 Jefferies London Healthcare Conference

November 10, 2021

From Aurinia Pharmaceuticals Inc.

Via Business Wire

Is Bristol Myers Squibb's Reported Acquisition of Aurinia a Smart Move? ↗

November 06, 2021

It could be.

Via The Motley Fool

What 5 Analyst Ratings Have To Say About Aurinia Pharmaceuticals ↗

November 04, 2021

Over the past 3 months, 5 analysts have published their opinion on Aurinia Pharmaceuticals (NASDAQ:

Via Benzinga

Aurinia Pharmaceuticals Inc (AUPH) Q3 2021 Earnings Call Transcript ↗

November 03, 2021

AUPH earnings call for the period ending September 30, 2021.

Via The Motley Fool

Topics Earnings

Here's Why Bristol Myers Squibb Can't Miss Out on Aurinia Pharmaceuticals ↗

November 03, 2021

The biopharma's takeover bid has failed to materialize after nearly two weeks. Here's what might be going on.

Via The Motley Fool

Aurinia Pharmaceuticals: Q3 Earnings Insights ↗

November 03, 2021

Aurinia Pharmaceuticals (NASDAQ:AUPH) reported its Q3 earnings results on Wednesday, November 3, 2021 at 08:00 AM. Here's what investors need to know about the...

Via Benzinga

Aurinia Reports Third Quarter and Nine Months 2021 Financial Results and Company Updates

November 03, 2021

From Aurinia Pharmaceuticals Inc.

Via Business Wire

Aurinia Announces Updated Interim Results from the AURORA 2 Continuation Study of LUPKYNIS (voclosporin) for the Treatment of Lupus Nephritis

November 01, 2021

From Aurinia Pharmaceuticals Inc.

Via Business Wire

No Negative Reaction ↗

October 28, 2021

Today the impact of the Delta variant hit US GDP which was only 2% annualized, vs estimates of 2.6%, based on Q3 data which came out today.

Via Talk Markets

Benzinga's Top Ratings Upgrades, Downgrades For October 28, 2021 ↗

October 28, 2021

Upgrades For Boot Barn Holdings Inc (NYSE:

Via Benzinga

Aurinia Pharmaceuticals to Release Third Quarter 2021 Financial Results on November 3, 2021

October 27, 2021

From Aurinia Pharmaceuticals Inc.

Via Business Wire

Aurinia Pharmaceuticals to Present Five Abstracts at ASN Kidney Week 2021 and ACR Convergence 2021

October 26, 2021

From Aurinia Pharmaceuticals Inc.

Via Business Wire

Cyber Currency ↗

October 26, 2021

Canadian stocks are particularly buoyant and not just in energy which is a riser today because the loony is up against the buck.

Via Talk Markets

Aurinia Rockets — Again — On Rumored Bristol Marriage; Could Others Make A Pass? ↗

October 25, 2021

Aurinia stock hit another record Monday on Bristol's rumored takeover.

Via Investor's Business Daily

55 Biggest Movers From Friday ↗

October 25, 2021

Gainers Phunware, Inc. (NASDAQ: PHUN) shares jumped 471.2% to close at $8.74 on Friday. Phunware shares jumped over 45% on Thursday, possibly in sympathy with Digital World...

Via Benzinga

Why Aurinia Pharmaceuticals Stock Is Blasting Higher Today ↗

October 22, 2021

The biotech is reportedly in buyout talks with Bristol Myers Squibb.

Via The Motley Fool

Aurinia Pharma Stock Pops On Reports Of Looming Bristol Myers Takeover ↗

October 22, 2021

Bristol is reportedly interested in acquiring Aurinia, according to reports that sent AUPH stock flying before it was halted.

Via Investor's Business Daily

More Chinese Trouble ↗

October 14, 2021

A day after the consumer price rise there was another price rise for producer markets.

Via Talk Markets

A Bit Of A Recovery ↗

September 29, 2021

While Germany remains without a government, Japan has a new prime minister who will lead his party in the election this week.

Via Talk Markets

Pharma, Tech and Finance ↗

September 20, 2021

Good news on some drugs was not enough to boost stock markets.

Via Talk Markets

Aurinia Pharmaceuticals to Present at Upcoming September Investor Conferences

September 15, 2021

From Aurinia Pharmaceuticals Inc.

Via Business Wire

The Daily Biotech Pulse: Pfizer-BioNTech US Vaccine Contract, Summit Slumps On Adverse Regulatory Feedback, Cerevel CFO Departs ↗

September 22, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 20) Acceleron Pharma Inc. (...

Via Benzinga

Sunday Special ↗

September 12, 2021

I have a taste for nuclear electricity which France pioneered decades ago, building power stations along the Loire Valley and in other regions. So I took my taste for uranium into my US holdings.

Via Talk Markets

Topics Energy

Aurinia Pharmaceuticals to Participate in H.C. Wainwright 23rd Annual Global Investment Conference

September 10, 2021

From Aurinia Pharmaceuticals Inc.

Via Business Wire

The Daily Biotech Pulse: Lilly, Regeneron Ink COVID-19 Drug Deal With US, Regulatory Setback For Calliditas, Theravance To Cut 75% Jobs, 4 IPOs ↗

September 15, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 14) Alcon Inc. (NYSE: ALC)...

Via Benzinga

Post-Rosh Hashanah, Sell? ↗

September 08, 2021

As the saying goes, sell Rosh Hashanah and buy Yom Kippur. Does it apply this year?

Via Talk Markets

The Daily Biotech Pulse: NRx Rises On COVID-19 Drug Collaboration, Amgen's Lung Cancer Drug Conditionally Approved In Canada, Coherus Data Readout ↗

September 14, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 13) Abbott Laboratories (NYSE...

Via Benzinga

Aurinia Pharmaceuticals finalizes acquisition agreement with Leading Pharma Giant

August 26, 2021

Via Get News

Aurinia Answers 'What's Next?' And Investors Punish AUPH Stock ↗

August 17, 2021

Aurinia snagged a pair of early-stage drugs for roughly $6.8 million on Tuesday, but AUPH stock tumbled into a key moving average.

Via Investor's Business Daily

< Previous 1 2

...

6 7 8 9 10 11 12 13 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.